207 related articles for article (PubMed ID: 34433378)
21. Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.
Ayar Y; Ersoy A; Ocakoglu G; Yildiz A; Oruc A; Soyak H; Calapkulu M; Sahin AB; Topal NB; Okeer E; Coskun B; Kaygisiz O; Kordan Y; Vuruskan H
Transplant Proc; 2017 Mar; 49(2):270-277. PubMed ID: 28219583
[TBL] [Abstract][Full Text] [Related]
22. Serum Uric Acid and Renal Transplantation Outcomes: At Least 3-Year Post-transplant Retrospective Multivariate Analysis.
Zhang K; Gao B; Wang Y; Wang G; Wang W; Zhu Y; Yao L; Gu Y; Chen M; Zhou H; Fu Y
PLoS One; 2015; 10(7):e0133834. PubMed ID: 26208103
[TBL] [Abstract][Full Text] [Related]
23. High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3a.
Moriyama T; Itabashi M; Takei T; Kataoka H; Sato M; Shimizu A; Iwabuchi Y; Nishida M; Uchida K; Nitta K
J Nephrol; 2015 Aug; 28(4):451-6. PubMed ID: 25355499
[TBL] [Abstract][Full Text] [Related]
24. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
[TBL] [Abstract][Full Text] [Related]
25. Extreme hyperuricemia is a risk factor for infection-related deaths in incident dialysis patients: a multicenter prospective cohort study.
Yoshida H; Inaguma D; Koshi-Ito E; Ogata S; Kitagawa A; Takahashi K; Koide S; Hayashi H; Hasegawa M; Yuzawa Y; Tsuboi N
Ren Fail; 2020 Nov; 42(1):646-655. PubMed ID: 32662307
[TBL] [Abstract][Full Text] [Related]
26. Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients?
Armstrong KA; Johnson DW; Campbell SB; Isbel NM; Hawley CM
Transplantation; 2005 Dec; 80(11):1565-71. PubMed ID: 16371927
[TBL] [Abstract][Full Text] [Related]
27. Early onset hyperuricemia is a prognostic marker for kidney graft failure: Propensity score matching analysis in a Korean multicenter cohort.
Han M; Lee JP; Park S; Kim Y; Kim YC; Ahn C; Han DJ; Ha J; Jung IM; Lim CS; Kim YS; Kim YH; Oh YK
PLoS One; 2017; 12(5):e0176786. PubMed ID: 28467476
[TBL] [Abstract][Full Text] [Related]
28. Hyperuricemia predicts kidney disease progression after acute allograft dysfunction.
Weng SC; Shu KH; Wu MJ; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Tarng DC
Transplant Proc; 2014; 46(2):499-504. PubMed ID: 24655999
[TBL] [Abstract][Full Text] [Related]
29. U-Shaped Association Between Serum Uric Acid and Short-Term Mortality in Patients With Infective Endocarditis.
Wei X; Fu B; Chen X; Chen W; Wang Z; Yu D; Jiang G; Chen J
Front Endocrinol (Lausanne); 2021; 12():750818. PubMed ID: 34795640
[TBL] [Abstract][Full Text] [Related]
30. Hyperuricemia in acute heart failure. More than a simple spectator?
Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study.
Okura T; Higaki J; Kurata M; Irita J; Miyoshi K; Yamazaki T; Hayashi D; Kohro T; Nagai R;
Circ J; 2009 May; 73(5):885-91. PubMed ID: 19336924
[TBL] [Abstract][Full Text] [Related]
32. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
[TBL] [Abstract][Full Text] [Related]
33. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
Karbowska A; Boratynska M; Kusztal M; Klinger M
Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
[TBL] [Abstract][Full Text] [Related]
34. Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.
Wang S; Shu Z; Tao Q; Yu C; Zhan S; Li L
Nephrology (Carlton); 2011 Nov; 16(8):767-76. PubMed ID: 21854506
[TBL] [Abstract][Full Text] [Related]
35. Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Tscharre M; Herman R; Rohla M; Hauser C; Farhan S; Freynhofer MK; Huber K; Weiss TW
Atherosclerosis; 2018 Mar; 270():173-179. PubMed ID: 29432935
[TBL] [Abstract][Full Text] [Related]
36. Impact of Uric Acid Levels on Kidney Disease Progression.
Rincon-Choles H; Jolly SE; Arrigain S; Konig V; Schold JD; Nakhoul G; Navaneethan SD; Nally JV; Rothberg MB
Am J Nephrol; 2017; 46(4):315-322. PubMed ID: 29032376
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients.
Sofue T; Inui M; Hara T; Nishijima Y; Moriwaki K; Hayashida Y; Ueda N; Nishiyama A; Kakehi Y; Kohno M
Drug Des Devel Ther; 2014; 8():245-53. PubMed ID: 24600205
[TBL] [Abstract][Full Text] [Related]
38. Risk Factors of Hyperuricemia After Renal Transplantation and Its Long-term Effects on Graft Functions.
Eyupoglu S; Eyupoglu D; Kendi-Celebi Z; Akturk S; Tuzuner A; Keven K; Sengul S
Transplant Proc; 2017 Apr; 49(3):505-508. PubMed ID: 28340822
[TBL] [Abstract][Full Text] [Related]
39. Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review.
Tsai CW; Lin SY; Kuo CC; Huang CC
PLoS One; 2017; 12(1):e0170393. PubMed ID: 28107415
[TBL] [Abstract][Full Text] [Related]
40. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
Nossent J; Raymond W; Divitini M; Knuiman M
BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
